WATERS CORP (WAT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for WAT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| WAT | Independent Director | 54 | ["Significant healthcare industry expertise from nearly 30 years of experience","Global experience driving commercial execution across the MedTech industry","Successful track record of building high-performance culture with a focus on human capital management and talent development"] | ["Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BAX | Executive Vice President and Chief Operating Officer (COO); Executive Vice President, COO and Interim Group President, Medical Products & Therapies | ["proven leader", "driven outstanding performance", "led profitable growth and enhanced innovation since joining in 2019"] | [] | 2025 |
Biography sourced from the proxy statement filing.
Independent Director since 2024 Age: 54 COMMITTEES Nominating and Corporate Governance Ms. Knight brings significant healthcare industry expertise from nearly 30 years of experience in commercial leadership positions across the pharmaceutical and medical device sectors, which enhances the Board s knowledge of the evolving industry landscape. Global experience driving commercial execution across the MedTech industry, including at and at Solventum Corporation, where she currently oversees global commercial and R&D operations across Solventum s MedSurg, Dental Solutions and Health Information Systems segments Brings successful track record of building high-performance culture, with deep focus on human capital management and talent development. CAREER HIGHLIGHTS Solventum Corporation Chief Commercial Officer (November 2025 present) Baxter International Inc. Chief Operating Officer (February 2025 October 2025), EVP and Group President, Medical Products & Therapies (2023 October 2025), President, Acute Therapies, Clinical Nutrition, Medication Delivery, Latin America and Canada (2021 2023), General Manager, U.S. Hospital Products (2019 2021) Medtronic plc VP, General Manager (2016 2019) OTHER PUBLIC COMPANY BOARDS None FORMER (PAST 5 YEARS) Titan Medical Inc. (NASDAQ: TMDI) (2021 2023) EDUCATION BS, University of Buffalo